Safety and immunogenicity of vaccines against SARS-CoV-2
The mortality rate estimated by the WHO worldwide for COVID-19 has been 5.7%, much higher than other communicable infectious diseases, so it is essential to apply a vaccine to the population to reduce the viral spread, according to the WHO there are 23 projects in clinical phase stage III, such as v...
Guardado en:
| Publicado en: | Archivos Venezolanos de Farmacología y Terapéutica |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Sociedad Venezolana de Farmacología Clínica y Terapéutica
2021
|
| Materias: | |
| Acceso en línea: | https://www.redalyc.org/articulo.oa?id=55971716011 https://www.redalyc.org/journal/559/55971716011/ https://www.redalyc.org/journal/559/55971716011/html/ https://www.redalyc.org/journal/559/55971716011/55971716011.epub https://www.redalyc.org/journal/559/55971716011/movil https://doi.org/10.5281/zenodo.5839028 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|